Concepts (182)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 29 | 2019 | 397 | 3.500 |
Why?
|
| Sputum | 10 | 2019 | 33 | 2.120 |
Why?
|
| Eosinophils | 10 | 2019 | 48 | 1.670 |
Why?
|
| Severity of Illness Index | 14 | 2019 | 863 | 1.350 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 5 | 2019 | 120 | 1.100 |
Why?
|
| Lung | 8 | 2018 | 233 | 1.070 |
Why?
|
| Bronchodilator Agents | 6 | 2019 | 82 | 0.700 |
Why?
|
| Neutrophils | 5 | 2019 | 102 | 0.660 |
Why?
|
| Bronchoalveolar Lavage Fluid | 8 | 2019 | 67 | 0.620 |
Why?
|
| Adrenal Cortex Hormones | 4 | 2019 | 148 | 0.580 |
Why?
|
| Epithelial Cells | 4 | 2019 | 138 | 0.580 |
Why?
|
| Leukocyte Count | 6 | 2019 | 55 | 0.510 |
Why?
|
| Cell Adhesion Molecules | 2 | 2006 | 45 | 0.500 |
Why?
|
| Bronchial Provocation Tests | 3 | 2003 | 14 | 0.500 |
Why?
|
| Phosphoproteins | 2 | 2006 | 54 | 0.490 |
Why?
|
| Phenotype | 6 | 2019 | 629 | 0.490 |
Why?
|
| Forced Expiratory Volume | 7 | 2017 | 112 | 0.490 |
Why?
|
| Adrenergic beta-Agonists | 3 | 2019 | 50 | 0.440 |
Why?
|
| Albuterol | 2 | 2017 | 40 | 0.420 |
Why?
|
| Granulocytes | 2 | 2013 | 12 | 0.400 |
Why?
|
| Inflammation | 5 | 2019 | 508 | 0.380 |
Why?
|
| Cytokines | 4 | 2018 | 243 | 0.360 |
Why?
|
| Adult | 20 | 2019 | 8426 | 0.350 |
Why?
|
| Receptors, Adrenergic, beta-2 | 2 | 2014 | 36 | 0.350 |
Why?
|
| Humans | 34 | 2019 | 29123 | 0.340 |
Why?
|
| Male | 24 | 2019 | 17815 | 0.340 |
Why?
|
| Female | 24 | 2019 | 18173 | 0.330 |
Why?
|
| Microfilament Proteins | 2 | 2006 | 33 | 0.330 |
Why?
|
| Interleukin-6 | 4 | 2019 | 225 | 0.320 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2009 | 84 | 0.310 |
Why?
|
| Education, Medical, Graduate | 1 | 2009 | 116 | 0.310 |
Why?
|
| Middle Aged | 17 | 2019 | 10834 | 0.310 |
Why?
|
| ROC Curve | 3 | 2017 | 149 | 0.300 |
Why?
|
| Respiratory System | 2 | 2017 | 12 | 0.290 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2006 | 13 | 0.280 |
Why?
|
| Immunoglobulin E | 5 | 2019 | 47 | 0.270 |
Why?
|
| Collagen Type III | 2 | 2003 | 13 | 0.270 |
Why?
|
| Gene Expression | 2 | 2019 | 332 | 0.260 |
Why?
|
| Fibroblasts | 2 | 2003 | 103 | 0.250 |
Why?
|
| Bronchoscopy | 4 | 2017 | 56 | 0.240 |
Why?
|
| Antigenic Modulation | 1 | 2003 | 2 | 0.230 |
Why?
|
| Adolescent | 10 | 2019 | 3255 | 0.230 |
Why?
|
| Spirometry | 3 | 2019 | 32 | 0.220 |
Why?
|
| Myofibrils | 1 | 2002 | 10 | 0.210 |
Why?
|
| Cluster Analysis | 3 | 2019 | 128 | 0.190 |
Why?
|
| Disease Progression | 3 | 2017 | 572 | 0.190 |
Why?
|
| Smoking | 3 | 2019 | 427 | 0.190 |
Why?
|
| Young Adult | 7 | 2019 | 2402 | 0.190 |
Why?
|
| Muscle, Smooth | 2 | 2015 | 73 | 0.190 |
Why?
|
| Child | 7 | 2017 | 2219 | 0.180 |
Why?
|
| Cohort Studies | 7 | 2019 | 1688 | 0.170 |
Why?
|
| Fungi | 1 | 2018 | 5 | 0.170 |
Why?
|
| Interleukin-7 | 1 | 2018 | 11 | 0.170 |
Why?
|
| European Continental Ancestry Group | 2 | 2014 | 1131 | 0.160 |
Why?
|
| Mycoses | 1 | 2018 | 13 | 0.160 |
Why?
|
| Bronchitis, Chronic | 1 | 2017 | 2 | 0.160 |
Why?
|
| Glucocorticoids | 1 | 2019 | 149 | 0.160 |
Why?
|
| DNA | 1 | 2019 | 204 | 0.160 |
Why?
|
| Pulmonary Alveoli | 1 | 2017 | 19 | 0.160 |
Why?
|
| Mucins | 1 | 2017 | 18 | 0.160 |
Why?
|
| Eosinophilia | 1 | 2017 | 16 | 0.150 |
Why?
|
| Respiratory Function Tests | 5 | 2017 | 111 | 0.150 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2016 | 1079 | 0.150 |
Why?
|
| Drug Resistance | 1 | 2017 | 36 | 0.150 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2010 | 152 | 0.140 |
Why?
|
| Vital Capacity | 2 | 2013 | 44 | 0.140 |
Why?
|
| Longitudinal Studies | 4 | 2019 | 721 | 0.130 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 481 | 0.130 |
Why?
|
| Immunophenotyping | 1 | 2015 | 49 | 0.130 |
Why?
|
| Trachea | 1 | 2015 | 55 | 0.130 |
Why?
|
| Genome-Wide Association Study | 2 | 2016 | 543 | 0.130 |
Why?
|
| Blotting, Western | 3 | 2019 | 281 | 0.120 |
Why?
|
| Administration, Inhalation | 3 | 2019 | 92 | 0.120 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 320 | 0.120 |
Why?
|
| Th1 Cells | 1 | 2013 | 18 | 0.110 |
Why?
|
| Receptors, Tumor Necrosis Factor | 2 | 2003 | 45 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 836 | 0.110 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2012 | 13 | 0.110 |
Why?
|
| Obesity | 2 | 2017 | 1063 | 0.110 |
Why?
|
| Aged | 4 | 2017 | 9492 | 0.110 |
Why?
|
| Phosphorylation | 2 | 2015 | 225 | 0.100 |
Why?
|
| Protein Array Analysis | 1 | 2010 | 16 | 0.090 |
Why?
|
| Child, Preschool | 2 | 2013 | 1167 | 0.090 |
Why?
|
| Signal Transduction | 4 | 2019 | 666 | 0.090 |
Why?
|
| Inflammation Mediators | 1 | 2010 | 101 | 0.090 |
Why?
|
| Case-Control Studies | 3 | 2019 | 859 | 0.090 |
Why?
|
| Linear Models | 1 | 2010 | 426 | 0.080 |
Why?
|
| Age Factors | 3 | 2017 | 1108 | 0.080 |
Why?
|
| Hispanic Americans | 1 | 2014 | 904 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2018 | 47 | 0.070 |
Why?
|
| African Americans | 1 | 2014 | 1373 | 0.070 |
Why?
|
| Superoxide Dismutase | 1 | 2005 | 47 | 0.070 |
Why?
|
| Apoptosis | 2 | 2003 | 337 | 0.060 |
Why?
|
| Transforming Growth Factors | 1 | 2003 | 3 | 0.060 |
Why?
|
| Interleukin-5 | 1 | 2003 | 7 | 0.060 |
Why?
|
| Actins | 1 | 2003 | 52 | 0.060 |
Why?
|
| Allergens | 1 | 2002 | 16 | 0.060 |
Why?
|
| Membrane Glycoproteins | 1 | 2002 | 97 | 0.050 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2002 | 15 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2002 | 200 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2002 | 256 | 0.050 |
Why?
|
| Bronchi | 2 | 2016 | 41 | 0.050 |
Why?
|
| Cell Culture Techniques | 1 | 2002 | 165 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2016 | 1362 | 0.050 |
Why?
|
| Macrophages, Alveolar | 1 | 2019 | 9 | 0.050 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 26 | 0.040 |
Why?
|
| Cyclic AMP | 1 | 2019 | 40 | 0.040 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 2019 | 2 | 0.040 |
Why?
|
| Lymphocytes | 1 | 2019 | 53 | 0.040 |
Why?
|
| Interleukin-8 | 1 | 2019 | 23 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2019 | 8 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2019 | 14 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2019 | 94 | 0.040 |
Why?
|
| Fibrinogen | 1 | 2019 | 42 | 0.040 |
Why?
|
| Acute Disease | 1 | 2019 | 239 | 0.040 |
Why?
|
| Chemokines | 1 | 2018 | 35 | 0.040 |
Why?
|
| Th2 Cells | 1 | 2018 | 14 | 0.040 |
Why?
|
| United States | 2 | 2019 | 3632 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2019 | 503 | 0.040 |
Why?
|
| Mucin-5B | 1 | 2017 | 3 | 0.040 |
Why?
|
| Mucin 5AC | 1 | 2017 | 3 | 0.040 |
Why?
|
| C-Reactive Protein | 1 | 2019 | 232 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2019 | 641 | 0.040 |
Why?
|
| Medication Adherence | 1 | 2019 | 144 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2017 | 99 | 0.040 |
Why?
|
| Breath Tests | 1 | 2017 | 17 | 0.040 |
Why?
|
| Prednisolone | 1 | 2017 | 10 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2017 | 53 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2018 | 469 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2017 | 186 | 0.040 |
Why?
|
| Time Factors | 1 | 2002 | 2001 | 0.040 |
Why?
|
| DNA Repair Enzymes | 1 | 2016 | 16 | 0.040 |
Why?
|
| Analysis of Variance | 1 | 2017 | 454 | 0.040 |
Why?
|
| Nitric Oxide | 1 | 2017 | 116 | 0.040 |
Why?
|
| Chi-Square Distribution | 1 | 2017 | 293 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 142 | 0.030 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2017 | 154 | 0.030 |
Why?
|
| Comorbidity | 1 | 2017 | 540 | 0.030 |
Why?
|
| Sample Size | 1 | 2015 | 37 | 0.030 |
Why?
|
| Risk Factors | 2 | 2013 | 3537 | 0.030 |
Why?
|
| Leukocytes | 1 | 2015 | 52 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 155 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 248 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2015 | 172 | 0.030 |
Why?
|
| Cell Separation | 1 | 2015 | 86 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2015 | 61 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2015 | 91 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2017 | 865 | 0.030 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2014 | 71 | 0.030 |
Why?
|
| Interferon Regulatory Factor-2 | 1 | 2013 | 5 | 0.030 |
Why?
|
| STAT4 Transcription Factor | 1 | 2013 | 16 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2015 | 514 | 0.030 |
Why?
|
| Interleukin-12 | 1 | 2013 | 26 | 0.030 |
Why?
|
| Macrophages | 1 | 2015 | 188 | 0.030 |
Why?
|
| Research Design | 1 | 2015 | 286 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2015 | 573 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2013 | 332 | 0.030 |
Why?
|
| Airway Remodeling | 1 | 2011 | 5 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2012 | 192 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2011 | 95 | 0.030 |
Why?
|
| Hospitalization | 1 | 2014 | 417 | 0.020 |
Why?
|
| Infant | 1 | 2013 | 969 | 0.020 |
Why?
|
| Genotype | 1 | 2012 | 735 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2017 | 3101 | 0.020 |
Why?
|
| Glutathione Peroxidase | 1 | 2005 | 8 | 0.020 |
Why?
|
| Airway Obstruction | 1 | 2005 | 31 | 0.020 |
Why?
|
| Glutathione | 1 | 2005 | 37 | 0.020 |
Why?
|
| Amino Acids | 1 | 2005 | 41 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2005 | 223 | 0.010 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2003 | 2 | 0.010 |
Why?
|
| Caspase 9 | 1 | 2003 | 7 | 0.010 |
Why?
|
| Caspase 8 | 1 | 2003 | 9 | 0.010 |
Why?
|
| Caspases | 1 | 2003 | 31 | 0.010 |
Why?
|
| Tumor Necrosis Factor Decoy Receptors | 1 | 2002 | 3 | 0.010 |
Why?
|
| Immune Sera | 1 | 2002 | 9 | 0.010 |
Why?
|
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2002 | 6 | 0.010 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2002 | 10 | 0.010 |
Why?
|
| Solubility | 1 | 2002 | 38 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2002 | 33 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2003 | 131 | 0.010 |
Why?
|
| Cell Survival | 1 | 2002 | 272 | 0.010 |
Why?
|
| Cell Movement | 1 | 2002 | 161 | 0.010 |
Why?
|